You have read all your free articles, to continue reading subscribe to read the rest of this content.
All patients in the company's phase I part of the CANFOUR clinical trial have completed the formal safety evaluation phase of the trial and no dose limiting toxicities (DLTs) were reported at the highest dose level investigated, 10 mg/kg. According to the study protocol, the patients continue CANAlready a subscriber…
AstraZeneca has filed a Clinical Trial Application (CTA) with the Paul Ehrlich Institute and the German Federal Ministry of Health to initiate a Phase I clinical trial of AZD8601. The programme is part of a collaboration between AstraZeneca and Moderna to discover, develop and commercialise messeAlready a subscriber Login You…
Gesynta Pharma has reported positive Phase I results with GS-248 for the treatment of microvascular disease. The Phase I study was designed to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of single oral doses up to 300 mg and multiple once daily doses up to 180 mg for 10Already a…
Nykode Therapeutics has announced clinical results from the open label, dose escalation trial of its T cell focused pan-SARS-CoV-2 vaccine candidate (VB10.2210) in healthy individuals who were previously vaccinated with an approved mRNA vaccine. T cell responses were analyzed by ex vivo ELISpot uAlready a subscriber Login You have read…
